Shantanu Chowdhury (born 1968) is an Indian structural biologist and a professor at Institute of Genomics and Integrative Biology of the Council of Scientific and Industrial Research.
[6] His post-doctoral studies were at the department of biochemistry of University of Nebraska and later at Max Planck Institute for Terrestrial Microbiology.
[1] The group focuses its studies on the control of NME2, a metastasis suppressor, on telomerase function and the biological action of DNA secondary structures like G-quadruplex.
[11] He is a member of the scientific advisory board of Bionivid, a Bengaluru-based information technology company involved in microarray data analytics and sequencing.
[12] and has delivered keynote addresses which included the discourse on Engineering Reversal of Drug Resistance in Cancer Cells at the Drug Discovery India 2016 conference held in Bengaluru in September 2016[1] and the address on The Emerging Story of DNA Quadruplexes in Genetic and Epigenetic Regulation at Asian Epigenomics 2016.